Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
Due to the lack of both prospective trial and high-volume retrospective studies, the management of clinical N+ malignant pleural mesothelioma (MPM) patients remains highly debated. Node positive patients show poor survival compared with node-negative ones; thus, lymph node staging appears crucial in...
Saved in:
Main Authors: | Sara Ricciardi, Francesco Carleo, Massimo O. Jaus, Marco Di Martino, Luigi Carbone, Alberto Ricci, Giuseppe Cardillo |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b19da1ba6c4f479ca290b86230e90ba0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Intraoperative Hypertonic Glucose Solution Administration on Persistent Air Leak After Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Retrospective Case–Control Study
by: Alberto Testori, et al.
Published: (2021) -
Clinical staging of malignant pleural mesothelioma: current perspectives
by: Bonomi M, et al.
Published: (2017) -
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
by: Giuseppe Mangiameli, et al.
Published: (2021) -
Serum Calretinin as a Biomarker in Malignant Mesothelioma
by: Cita Zupanc, et al.
Published: (2021) -
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
by: Hiroto Yoneda, et al.
Published: (2021)